248 related articles for article (PubMed ID: 30424932)
1. Gastric MALT lymphoma and Helicobacter pylori.
Salar A
Med Clin (Barc); 2019 Jan; 152(2):65-71. PubMed ID: 30424932
[TBL] [Abstract][Full Text] [Related]
2. Helicobacter pylori-negative gastric mucosa-associated lymphoid tissue lymphomas: A review.
Asano N; Iijima K; Koike T; Imatani A; Shimosegawa T
World J Gastroenterol; 2015 Jul; 21(26):8014-20. PubMed ID: 26185372
[TBL] [Abstract][Full Text] [Related]
3. Helicobacter pylori: A Review of Current Diagnostic and Management Strategies.
Guevara B; Cogdill AG
Dig Dis Sci; 2020 Jul; 65(7):1917-1931. PubMed ID: 32170476
[TBL] [Abstract][Full Text] [Related]
4. [Helicobacter pylori-associated diseases].
Gisbert JP
Gastroenterol Hepatol; 2015 Sep; 38 Suppl 1():39-48. PubMed ID: 26520195
[TBL] [Abstract][Full Text] [Related]
5. Increased plasmacytic differentiation in gastric mucosa-associated lymphoid tissue lymphomas: Helicobacter pylori eradication response and IgG4+ plasma cell association.
Park S; Ahn S; Hong M; Ko YH
Hum Pathol; 2017 Jan; 59():113-119. PubMed ID: 27697589
[TBL] [Abstract][Full Text] [Related]
6. Treatment of low-grade gastric MALT lymphoma using Helicobacter pylori eradication.
Grgov S; Katić V; Krstić M; Nagorni A; Radovanović-Dinić B; Tasić T
Vojnosanit Pregl; 2015 May; 72(5):431-6. PubMed ID: 26165051
[TBL] [Abstract][Full Text] [Related]
7. Helicobacter pylori (HP) infection alone, but not HP-induced atrophic gastritis, increases the risk of gastric lymphoma: a case-control study in Japan.
Ishikura N; Usui Y; Ito H; Kasugai Y; Oze I; Kato S; Yatabe Y; Nakamura S; Matsuo K
Ann Hematol; 2019 Aug; 98(8):1981-1987. PubMed ID: 31177299
[TBL] [Abstract][Full Text] [Related]
8. Helicobacter suis infection is associated with nodular gastritis-like appearance of gastric mucosa-associated lymphoid tissue lymphoma.
Takigawa H; Masaki S; Naito T; Yuge R; Urabe Y; Tanaka S; Sentani K; Matsuo T; Matsuo K; Chayama K; Kitadai Y
Cancer Med; 2019 Aug; 8(9):4370-4379. PubMed ID: 31210418
[TBL] [Abstract][Full Text] [Related]
9. The role of Helicobacter pylori eradication in the treatment of diffuse large B-cell and marginal zone lymphomas of the stomach.
Ferreri AJ; Govi S; Ponzoni M
Curr Opin Oncol; 2013 Sep; 25(5):470-9. PubMed ID: 23942292
[TBL] [Abstract][Full Text] [Related]
10. Strategy for the treatment of Helicobacter pylori infection.
Shiota S; Yamaoka Y
Curr Pharm Des; 2014; 20(28):4489-500. PubMed ID: 24180402
[TBL] [Abstract][Full Text] [Related]
11. Modified sequential therapy vs quadruple therapy as initial therapy in patients with Helicobacter infection.
Liao XM; Nong GH; Chen MZ; Huang XP; Cong YY; Huang YY; Wu BH; Wei JQ
World J Gastroenterol; 2015 May; 21(20):6310-6. PubMed ID: 26034367
[TBL] [Abstract][Full Text] [Related]
12. Concomitant, bismuth quadruple, and 14-day triple therapy in the first-line treatment of Helicobacter pylori: a multicentre, open-label, randomised trial.
Liou JM; Fang YJ; Chen CC; Bair MJ; Chang CY; Lee YC; Chen MJ; Chen CC; Tseng CH; Hsu YC; Lee JY; Yang TH; Luo JC; Chang CC; Chen CY; Chen PY; Shun CT; Hsu WF; Hu WH; Chen YN; Sheu BS; Lin JT; Wu JY; El-Omar EM; Wu MS;
Lancet; 2016 Nov; 388(10058):2355-2365. PubMed ID: 27769562
[TBL] [Abstract][Full Text] [Related]
13. Molecular approaches and modern clinical strategies for the management of Helicobacter pylori infection in Japan.
Suzuki H; Nishizawa T; Tsugawa H; Hibi T
Keio J Med; 2012; 61(4):109-19. PubMed ID: 23324305
[TBL] [Abstract][Full Text] [Related]
14. Helicobacter pylori and gastric mucosa-associated lymphoid tissue lymphoma: recent progress in pathogenesis and management.
Nakamura S; Matsumoto T
World J Gastroenterol; 2013 Dec; 19(45):8181-7. PubMed ID: 24363507
[TBL] [Abstract][Full Text] [Related]
15. The spectrum of MALT lymphoma at different sites: biological and therapeutic relevance.
Zucca E; Bertoni F
Blood; 2016 Apr; 127(17):2082-92. PubMed ID: 26989205
[TBL] [Abstract][Full Text] [Related]
16. Pylera and sequential therapy for first-line Helicobacter pylori eradication: a culture-based study in real clinical practice.
Fiorini G; Zullo A; Saracino IM; Gatta L; Pavoni M; Vaira D
Eur J Gastroenterol Hepatol; 2018 Jun; 30(6):621-625. PubMed ID: 29481383
[TBL] [Abstract][Full Text] [Related]
17. Treatment of gastric MALT lymphoma with a focus on Helicobacter pylori eradication.
Guo Q; Guo S; Zhang Y
Int J Hematol; 2013 Jun; 97(6):735-42. PubMed ID: 23616223
[TBL] [Abstract][Full Text] [Related]
18. IV Spanish Consensus Conference on Helicobacter pylori infection treatment.
Gisbert JP; Molina-Infante J; Amador J; Bermejo F; Bujanda L; Calvet X; Castro-Fernández M; Cuadrado-Lavín A; Elizalde JI; Gene E; Gomollón F; Lanas Á; Martín de Argila C; Mearin F; Montoro M; Pérez-Aisa Á; Pérez-Trallero E; McNicholl AG
Gastroenterol Hepatol; 2016 Dec; 39(10):697-721. PubMed ID: 27342080
[TBL] [Abstract][Full Text] [Related]
19. Concomitant therapy achieved the best eradication rate for Helicobacter pylori among various treatment strategies.
Lee HJ; Kim JI; Lee JS; Jun EJ; Oh JH; Cheung DY; Chung WC; Kim BW; Kim SS
World J Gastroenterol; 2015 Jan; 21(1):351-9. PubMed ID: 25574111
[TBL] [Abstract][Full Text] [Related]
20. Patients with gastric MALT lymphoma revealing persisting endoscopic abnormalities after successful eradication of Helicobacter pylori can be safely managed by a watch-and-wait strategy.
Fischbach W; Dorlöchter C
Z Gastroenterol; 2019 May; 57(5):593-599. PubMed ID: 31083747
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]